← FDA Drug Approvals (Drugs@FDA)
TADALAFIL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2019-03-26
Drug application
- FDA Application #
ANDA209539- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TADALAFIL
- Generic name
- Tadalafil
- Active ingredients
- TADALAFIL
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- CIPLA
- First approval
- 2019-03-26
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown